Articles
View all articles-
US import alert on Wockhardt spooks St: All you need to know
The Wockhardt news comes just days after another pharma company Ranbaxy , now owned by Japan's Daiichi Sankyo, pleaded guilty to felony charges in the US #StockWatch #Wockhardt #Ranbaxy #Pharma
-
Ranbaxy: Despite Malvinders clean chit to self, troubles may be brewing
Despite all these denials, Malvinder and Shivinder Singh may be in for a little bit of trouble and the way out is unlikely to be easy. There are chances that Daiichi may indeed go ahead with the legal case. #ToWhatEffect #Ranbaxy #Healthcare #Pharma #Daiichi Sankyo #Malvinder Singh #Dinesh Thakur
-
Malvinder Singh hits back at Daiichi, insists FDA charges were in public domain
A day after pharma major Daiichi Sankyo alleged that certain former shareholders of Ranbaxy concealed and misrepresented critical information about the US justice department and the USFDA probe, former Ranbaxy CEO Malvinder Singh denied any wrongdoing at Ranbaxy #TheySaidIt #Ranbaxy #Daiichi Sankyo #Malvinder Singh
Blog posts
View all blog posts-
Its not just Ranbaxy, our health care regulators have failed us too
The Ranbaxy saga of fraud and greed goes beyond that. In India, it shows how our regulators too have failed us. #TheLongView #Health #Drugs #Ranbaxy #Healthcare #Pharma
-
India, US firms join hands to make HIV war affordable
A big US pharma company has finally taken proactive measures (learning from history no doubt) to license innovative drugs to low-cost drug makers in India so that they reach the people who need them the most. #Ranbaxy Laboratories #GeekSpeak #HIV/AIDS #Antiretroviral drug #Gilead Sciences
Wire
-
Keralanext
It was perhaps too late for Daiichi to exit Ranbaxy after USFDA action
Three months after Daiichi Sankyo, Japan's number three drugmaker, entered a deal in June 2008 to buy 63.9% stake in Ranbaxy from the controlling shareholder group led by brothers Malvinder Singh and Shivinder Singh for $4.2 billion, the USFDA issued imp #Daiichi Sankyo #U.S. Department of Justice #India
-
Calcutta Telegraph
Ranbaxy past troubles Daiichi
Mumbai, May 22: Daiichi Sankyo Company of Japan is weighing its legal options against the former promoters of Ranbaxy Laboratories for misleading it about the investigations by the US Food & Drugs Administration (FDA) and the US Department of Justice (Do #Daiichi Sankyo #Mumbai #Food and Drug Administration
-
Channel News Asia
Former Ranbaxy owners deny hiding drug probe detail
NEW DELHI: The billionaire ex-owners of Ranbaxy denied Thursday charges by the Japanese buyers of the Indian generics giant that they hid key details about a US probe into the safety of the company's drugs. Daiichi Sankyo alleged Wednesday former shareho #New Delhi #Daiichi Sankyo #India




